Table 4.
Future market shares and prices (based on defined daily dose)
| Before paliperidone palmitate (t =0)
|
After paliperidone palmitate (t= 1)
|
Post-paliperidone palmitate (t =2)
|
Post-paliperidone palmitate (t =3)
|
|||||
|---|---|---|---|---|---|---|---|---|
| Market share (%) | Daily price (yen) | Market share (%) | Daily price (yen) | Market share (%) | Daily price (yen) | Market share (%) | Daily price (yen) | |
| Paliperidone palmitate (LAI) (Xeplion®) | 0.03 | 1,411.82 | 0.19 | 1,430.39 | 0.35 | 1,430.39 | 0.74 | 1,430.39 |
| Risperidone (LAI) (Risperdal Consta®) | 0.64 | 2,214.07 | 0.45 | 2,277.36 | 0.35 | 2,277.36 | 0.27 | 2,277.36 |
| Risperidone (oral) (Risperdal®) | 12.44 | 149.40 | 10.92 | 135.90 | 9.51 | 135.90 | 8.70 | 122.30 |
| Risperidone (oral) GE | 10.68 | 76.50 | 11.74 | 65.30 | 12.73 | 65.30 | 13.04 | 45.80 |
| Olanzapine (oral) (Zyprexa®) | 14.82 | 476.80 | 15.30 | 489.90 | 15.53 | 489.90 | 12.32 | 411.50 |
| Olanzapine (oral) GE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 258.70 | 3.46 | 219.90 |
| Aripiprazole (Abilify®) | 13.76 | 435.10 | 15.35 | 447.50 | 14.84 | 447.50 | 11.43 | 375.90 |
| Aripiprazole GE | 0.00 | 0.00 | 0.00 | 0.00 | 1.55 | 236.30 | 6.07 | 200.90 |
| Quetiapine (oral) (Seroquel®) | 13.77 | 621.80 | 10.88 | 537.40 | 8.49 | 537.40 | 7.72 | 456.80 |
| Quetiapine (oral) GE | 4.93 | 335.80 | 8.01 | 233.80 | 10.62 | 233.80 | 11.58 | 163.80 |
| Blonanserin (Lonasen®) | 3.80 | 412.80 | 3.97 | 424.60 | 4.14 | 424.60 | 4.3 | 424.60 |
| Conventionals | 25.13 | 20.0 | 23.19 | 19.8 | 21.89 | 19.8 | 20.37 | 19.6 |
Note: Daily price is based on per patient.
Abbreviations: GE, generic drug; LAI, long-acting injectable; t, time (year).